Omega conotoxin peptides

US8765677B2 · kind B2 · utility

Assignees

• The University Of Queensland · AU
• The University of Sydney · AU

Inventors

• Richard James Lewis · Brisbane, AU
• David J. Adams · Warren, US
• Geza Berecki · Melbourne, AU
• Roger Drinkwater · Tarago, AU
• Paul Francis Alewood · Brisbane, AU
• MacDonald Christie · Sydney, AU

Key dates

• Filing date: Sep 21, 2010
• Grant date: Jul 1, 2014
• Expiry date: Sep 21, 2030

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to an isolated, synthetic or recombinant peptide, wherein the peptide comprises the sequence: C K G K G A Xaa1 C R Xaa2 Xaa3 Xaa4 Y Xaa5 C C Xaa6 G Xaa7 C R Xaa8 Xaa9 R C SEQ ID NO: 1 wherein Xaa1, Xaa3, Xaa4, Xaa6, Xaa7 and Xaa8 are independently selected from serine and threonine; Xaa2 is selected from arginine and lysine; Xaa5 is selected from aspartic acid and glutamic acid; and Xaa9 is selected from glycine, alanine, valine, leucine and isoleucine.